- Home
- SNTI vs GROV Comparison
SNTI vs GROV Comparison
Compare SNTI & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- GROV
- Stock Information
- Founded
- SNTI 2016
- GROV 2016
- Country
- SNTI United States
- GROV United States
- Employees
- SNTI N/A
- GROV N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- GROV Package Goods/Cosmetics
- Sector
- SNTI Health Care
- GROV Consumer Discretionary
- Exchange
- SNTI Nasdaq
- GROV Nasdaq
- Market Cap
- SNTI 53.6M
- GROV 55.0M
- IPO Year
- SNTI N/A
- GROV N/A
- Fundamental
- Price
- SNTI $2.05
- GROV $1.39
- Analyst Decision
- SNTI Strong Buy
- GROV Buy
- Analyst Count
- SNTI 4
- GROV 2
- Target Price
- SNTI $8.75
- GROV $1.60
- AVG Volume (30 Days)
- SNTI 97.8K
- GROV 115.8K
- Earning Date
- SNTI 11-13-2025
- GROV 11-13-2025
- Dividend Yield
- SNTI N/A
- GROV N/A
- EPS Growth
- SNTI N/A
- GROV N/A
- EPS
- SNTI N/A
- GROV N/A
- Revenue
- SNTI N/A
- GROV $180,808,000.00
- Revenue This Year
- SNTI N/A
- GROV N/A
- Revenue Next Year
- SNTI $150.00
- GROV $11.10
- P/E Ratio
- SNTI N/A
- GROV N/A
- Revenue Growth
- SNTI N/A
- GROV N/A
- 52 Week Low
- SNTI $1.26
- GROV $1.02
- 52 Week High
- SNTI $16.94
- GROV $1.95
- Technical
- Relative Strength Index (RSI)
- SNTI 56.53
- GROV 47.07
- Support Level
- SNTI $1.44
- GROV $1.29
- Resistance Level
- SNTI $2.16
- GROV $1.40
- Average True Range (ATR)
- SNTI 0.18
- GROV 0.08
- MACD
- SNTI 0.02
- GROV 0.00
- Stochastic Oscillator
- SNTI 84.03
- GROV 43.19
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.